EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

TSPO Radioligands for Neuroinflammation: An Overview

Silvia Salerno iD, Monica Viviano iD, Emma Baglini, Valeria Poggetti, Doralice Giorgini, Jacopo Castagnoli, Elisabetta Barresi iD, Sabrina Castellano, Federico Da Settimo iD, Sabrina Taliani iD

Molecules · 05.09.2024 · 29 (17) · 4212

DOI: 10.3390/molecules29174212 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 05.09.2024. Verfasst von Silvia Salerno und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126 Pisa, Italy. Hauptthemen laut MEDLINE: Neuroinflammatory Diseases, Receptors, GABA. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 169 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Education, Universities and Research (MIUR) by the funding of "projects of national interest, Italian Ministry of Education, Universities and Research (MIUR) by the funding of “projects of national interest.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The translocator protein (TSPO) is predominately localized on the outer mitochondrial membrane in steroidogenic cells. In the brain, TSPO expression, low under normal conditions, results upregulated in response to glial cell activation, that occurs in neuroinflammation. As a consequence, TSPO has been extensively studied as a biomarker of such conditions by means of TSPO-targeted radiotracers. Although [11C]-PK11195, the prototypical TSPO radioligand, is still widely used for in vivo studies, it is endowed with severe limitations, mainly low sensitivity and poor amenability to quantification. Consequently, several efforts have been focused on the design of new radiotracers for the in vivo imaging of TSPO. The present review will provide an outlook on the latest advances in TSPO radioligands for neuroinflammation imaging. The final goal is to pave the way for (radio)chemists in the future design and development of novel effective and sensitive radiopharmaceuticals targeting TSPO.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroinflammatory DiseasesReceptors, GABAAnimalsHumansBrainIsoquinolinesLigandsPositron-Emission TomographyRadiopharmaceuticals

Stichwörter der Autor:innen

diagnostic markerneuroinflammationradioligandtranslocator protein

Substanzen

IsoquinolinesLigandsRadiopharmaceuticalsReceptors, GABATSPO protein, human

Autor:innen und Institutionen

  • Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126 Pisa, Italy.
  • Department of Pharmacy, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, Italy.

ORCID-Profile: Silvia Salerno, Monica Viviano, Elisabetta Barresi, Federico Da Settimo, Sabrina Taliani

Förderung

  • Italian Ministry of Education, Universities and Research (MIUR) by the funding of "projects of national interest
  • Italian Ministry of Education, Universities and Research (MIUR) by the funding of “projects of national interest

Zitieren

APA

Salerno, S., Viviano, M., Baglini, E., Poggetti, V., Giorgini, D., Castagnoli, J., Barresi, E., Castellano, S., Da Settimo, F., & Taliani, S. (2024). TSPO Radioligands for Neuroinflammation: An Overview. Molecules, 29(17), 4212. https://doi.org/10.3390/molecules29174212

Vancouver

Salerno S, Viviano M, Baglini E, Poggetti V, Giorgini D, Castagnoli J, et al. TSPO Radioligands for Neuroinflammation: An Overview. Molecules. 2024;29(17):4212. doi:10.3390/molecules29174212

BibTeX
@article{Salerno2024,
  author = {Salerno, Silvia and Viviano, Monica and Baglini, Emma and Poggetti, Valeria and Giorgini, Doralice and Castagnoli, Jacopo and Barresi, Elisabetta and Castellano, Sabrina and Da Settimo, Federico and Taliani, Sabrina},
  title = {TSPO Radioligands for Neuroinflammation: An Overview},
  journal = {Molecules},
  year = {2024},
  volume = {29},
  number = {17},
  pages = {4212},
  doi = {10.3390/molecules29174212}
}
Kostenlos starten →